• Non ci sono risultati.

Hirudo medicinalis as alternative model for in vivo and in vitro studies on nanomaterials toxicity.

N/A
N/A
Protected

Academic year: 2021

Condividi "Hirudo medicinalis as alternative model for in vivo and in vitro studies on nanomaterials toxicity."

Copied!
1
0
0

Testo completo

(1)

Hirudo medicinalis AS ALTERNATIVE MODEL FOR

in vivo AND in vitro STUDIES ON NANOMATERIALS TOXICITY

Girardello R, de Eguileor M, Tettamanti G, Valvassori R and Grimaldi A.

DEPARTMENT OF BIOTECHNOLOGY AND LIFE SCIENCES, UNIVERSITY OF INSUBRIA, VARESE, ITALY

CONCLUSIONS: O ur combined experimental approaches, not only attest the ability of MWCNTs in inducing a potent inflammatory response, but also confirm H. medicinalis as a good alternative model that can be successfully used to study, both in vivo and in vitro, the possible harmful effects of any nanomaterial.

RESULTS:

Low concentration of MWCNTs dispersed in water evoke, in a short period (24h) a strong inflammatory response in the leech body wall involving monocyte-macrophages cells activation and migration. TEM analysis revealed that MWCNTs can enter cells both by diffusing through cell membranes (membrane piercing) and active uptake (phagocytosis). Within cells, MWCNTs accumulate and causes the decrease of cell proliferation rate and the increase of apoptosis and ROS production.

INTRODUCTION

: Nanomaterials (NMs) are widely used in industry. In particular multiwall carbon nanotubes (MWCNTs), consisting of several concentric graphene tubes with diameters of up to 100 nm, are employed for many applications (i.e. biomedicine, nanoelectronics, mechanical engineering), however they do not degrade and persist in biological systems for months or even years. For these reasons the risk assessment for this NM is becoming essential.

The immune system of organisms is one of the first frontiers affected by NMs and represents a sensitive physiological indicator which is affected even at low concentrations of NMs exposure. Here we propose the leech Hirudo medicinalis as new sentinel model for studying MWCNTs effects since its simple anatomy and its immune response processes are clear and easily interpretable.

THICK OR CURLED MWCNTs

MWCNTs INTERNALIZATION

B C

MWCNTs internalization mechanisms scheme (A) and TEM images (B-C). After injection, thin and straight MWCNTs are observed in the MG and freely dispersed in citosol (arrowheads in B), while thick or curled MWCNTs (arrows in C) are phagocytized by macrophages migrated in the MG. Bars in C, D: 1µm.

THIN AND STRAIGHT MWCNTs

n.t.

A

MWCNTs 100 µg/ml

24h

B

n.t. 2,5 µg/ml 5 µg/ml 10 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml

[MWCNTs]

48h 0,0

0,5 1,0 1,5 2,0 2,5 3,0 3,5 4,0 4,5

Normalized fluorescence intensity / surface unit

n.t. 2,5 µg/ml 5 µg/ml 10 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml

[MWCNTs]

24h 0,0

0,5 1,0 1,5 2,0 2,5 3,0 3,5 4,0 4,5

Normalized fluorescence intensity / surface unit

F

* * **

* ** **

*** H2DCFH-DA positivity (green) is not visible in n.t.

Macrophages (A). After 24h in vitro MWCNTs treatment positivity is detectable from 25 up to 100µg/ml (B). A dose-dependent ROS production is appreciable also after 48h treatment (B-E). Bars in A- E: 5 µm. Histogram showing fluorescence intensity for surface unit after H2DCFH-DA assay (F). Statistical differences were calculated by Factorial ANOVA followed by Tukey’s post-hoc test, vertical bars denote 0,95 confidence intervals, *p < 0.05, **p <

0.01, ***p < 0.001 (between n.t. and treatments).

REACTIVE OXYGEN SPECIES

MWCNTs 25 µg/ml 48h

C

MWCNTs 50 µg/ml 48h

D

MWCNTs 100 µg/ml 48h

E Ctrl+

Ctrl-

n.t.

MWCNTs 10 µg/ml MWCNTs 100 µg/ml 24h

24h

24h

24h 24h

A

B

C

MWCNTs 5 µg/ml 48h MWCNTs 50 µg/ml 48h MWCNTs 100 µg/ml48h

The percentages of TUNEL+ cells after in vitro MWCNTs treatment are illustrated in the graphs (I). Statistical differences were calculated by Factorial ANOVA followed by Tukey’s post-hoc test;

vertical bars denote 0,95 confidence intervals, different letters indicate statistically significant differences (p<0.01).

APOPTOSIS ASSAY

I

n.t. 2,5 µg/ml 5 µg/ml 10 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml

[MWCNTs]

24h

0 20 40 60 80 100

% TUNEL+ cells

a a a

b c c c

n.t. 2,5 µg/ml 5 µg/ml 10 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml

[MWCNTs]

48h

0 20 40 60 80 100

% TUNEL+ cells

a

d d d e e

f

TUNEL assay for apoptosis after 24h (A-I) and 48h (J-O)

in vitro

MWCNTs treatment.

Nuclei were counterstained with propidium iodide (red).

TUNEL

positivity is visible in green/yellow.

Bars in A-O: 20 µm.

D E

F G H

A

MWCNTs 2,5µg/ml

MWCNTs 100 µg/ml

24h

24h

B

C

MWCNTs 2,5µg/ml

MWCNTs 10 µg/ml

MWCNTs 50 µg/ml

48h

48h 48h

n.t. 2,5 µg/ml 5 µg/ml 10 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml

[MWCNTs]

24h

0 10 20 30 40 50 60 70 80 90 100

% BrdU+ cells

n.t. 2,5 µg/ml 5 µg/ml 10 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml

[MWCNTs]

48h

0 10 20 30 40 50 60 70 80 90 100

% BrdU+ cells

G

a a

b b

c c

cd ce

def f

ce ef

g g

n.t.

A

C

D

E

F

Compared to not treated samples (A), in which the major part of cells is BrdU+ (green), in 24 (B) and 48h (D-F)

MWCNTs treated

samples, the number of positive cells decreases.

Nuclei were

counterstained with DAPI (blue). Bars in A-F:

10 µm.

The graph (G) shows the percentage of BrdU+ cells after MWCNTs treatment showing a

dose and time-

dependent reduction of proliferative rate.

Different letters indicate statistically significant differences (Factorial ANOVA followed by Tukey’s post-hoc test, vertical bars: 0,95 confidence intervals, p<0.01).

MWCNTs 24 hours in vivo treatment causes a massive migration of CD68+ macrophage cells (red) in the leech body wall (A, B). These cells derive from CD45+ circulating precursors (C). TEM details showing circulating monocytes (D) in a blood vessel (v), during diapedesis (E) and a mature macrophage (F) in the extracellular matrix (ECM). Nuclei are counterstained with DAPI (blue). Bar in A: 100 µm;

bars in B, C: 10 µm; bars in D, F: 1µm; bar in E:

500nm.

C

A B D

E F

ECM v

v

AIMS

: Develop and optimize approaches to: 1) investigate the mode of action of MWCNTs on different levels of biological organisation from cells/tissue to individuals and the effects of this nanomaterial as stressor on organisms; 2) to give rapid and sensitive responses upon the presence of MWCNTs even if at low concentration.

MWCNTs in vitro treatment MWCNTs

in vivo injection MWCNTs

environmenta l dispersion

METHODS:

1)

in vivo exposure: MWCNTs were dispersed in leeches’ water.

2)

In vivo injection: MWCNTs

supplemented biomatrice (MG) was injected in the leech body wall.

3)

in vitro exposure: MWCNTs

were dispersed in the culture medium of macrophages.

e

in vivo exposur e

MWCNTs INDUCED IMMUNE RESPONSE

in vivo injec tion

PROLIFERATION ASSAY

in vitro exposur e in vitro exposur e

in vitro exposur e

Riferimenti

Documenti correlati

Different letters indicate significant differences according to Tukey's test (p &lt; 0.05). The FA-C, HA-C and NEOC fractions did not show any significant differences

[r]

Note that all the infinite products are convergent by

a) Durante l’urto si conserva il momento rispetto ad o, perch`e i momenti delle forze esterne agenti sul sistema sono tutti nulli: quello della reazione dell’asse perch`e `e

dove la costante di proporzionalità k è data dal prodotto degli stati accessibili nello spazio delle fasi, che è assunta uguale per entrambe le reazioni.. 3) Muoni

L’espressione logica SOMMA DI PRODOTTI (prima forma canonica) 2.. Dire se la copertura minima trovata

Conversely, the CIs reported for the NIRS and heart rate data were appropriate, since the native time resolution of these parameters is finest compared to the data acquisition one,

This paper gives an extensive overview of different AM techniques classes (i.e. stereolithography, selective laser sintering, three-dimensional printing, melt-extrusion